Author: Zhang, Yu; Chen, Shuaiyin; Jin, Yuefei; Ji, Wangquan; Zhang, Weiguo; Duan, Guangcai
Title: An Update on Innate Immune Responses during SARS-CoV-2 Infection Cord-id: 561iah8u Document date: 2021_10_14
ID: 561iah8u
Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the Coronaviridae family, which is responsible for the COVID-19 pandemic followed by unprecedented global societal and economic disruptive impact. The innate immune system is the body’s first line of defense against invading pathogens and is induced by a variety of cellular receptors that sense viral components. However, various strategies are exploited by SARS-CoV-2 to disrupt the antiviral innate immune responses
Document: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the Coronaviridae family, which is responsible for the COVID-19 pandemic followed by unprecedented global societal and economic disruptive impact. The innate immune system is the body’s first line of defense against invading pathogens and is induced by a variety of cellular receptors that sense viral components. However, various strategies are exploited by SARS-CoV-2 to disrupt the antiviral innate immune responses. Innate immune dysfunction is characterized by the weak generation of type I interferons (IFNs) and the hypersecretion of pro-inflammatory cytokines, leading to mortality and organ injury in patients with COVID-19. This review summarizes the existing understanding of the mutual effects between SARS-CoV-2 and the type I IFN (IFN-α/β) responses, emphasizing the relationship between host innate immune signaling and viral proteases with an insight on tackling potential therapeutic targets.
Search related documents:
Co phrase search for related documents- abnormal expression and activator signal transducer: 1
- abnormal expression and acute respiratory distress: 1
- abnormal expression and lung injury: 1, 2, 3
- abnormal expression and lung tissue: 1, 2
- accessory protein and activator signal transducer: 1, 2, 3
- accessory protein and acute respiratory distress: 1, 2, 3
- accessory protein and lung injury: 1, 2
- accessory protein and lung tissue: 1, 2
- accessory protein structural protein and acute respiratory distress: 1
- activator signal transducer and acute respiratory distress: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- activator signal transducer and adaptive immune response: 1, 2, 3, 4
- activator signal transducer and luciferase reporter: 1, 2, 3
- activator signal transducer and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- activator signal transducer and lung tissue: 1, 2, 3
- acute respiratory distress and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- acute respiratory distress and long incubation period: 1, 2, 3
- acute respiratory distress and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67
- acute respiratory distress and luciferase reporter: 1, 2, 3, 4, 5, 6
- acute respiratory distress and lung cytokine production: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date